1. Krill Oil: How its latest “success” proves it to be an epic failure…again

    256px-Fish_Oil_Capsules

    Image Source

    By Pointe Institute

    Those familiar with our work know that we have spent quite a bit of time evaluating the therapeutic outcomes of marine-derived omega-3 fatty acids. Our recent review of the topic has been downloaded and widely circulated amongst healthcare providers and the general public, worldwide. In that review, we covered the types of fish used, how fish oil is made, sustainability issues, bioavailability differences, quality control concerns and much more; including the research comparing omega-3 fatty acid from fish oil and krill oil. You can get the article as a PDF file here.

    Just a month after publishing our paper online, a few more studies comparing fish oil and krill oil were published that initially appeared to suggest that omega-3 fatty acids from krill oil may indeed have a slightly better bioavailability than those from fish oil and/or had triglyceride lowering effects similar to fish oil; but after only a month of scrutiny, these studies are exposed as epic failures of how marketing-driven research leads to bad science and confusing outcomes.

    First- as a brief review for those who haven’t read our whitepaper. Our position was that the EPA and DHA in krill oil should function in much the same way as EPA and DHA from fish oil- assuming equal amounts of the fatty acid become bioavailable after consumption. The typical claims made by the marketers of krill oil is that, because krill oil omega-3s are delivered as phospholipids (PL, rather than triglycerides), they will have (or have been shown to have) higher bioavailability than fish oil omega-3s. Our whitepaper clearly shows that the studies used by marketers to “prove” such assertions are either not clinically or statistically significant; or are not appropriately designed to make such comparisons. However, the biggest issue is not their failure to prove better bioavailability, or the fact that krill oil appears to be nearly ¼ free fatty acids upon analysis (not all PL as claimed); but the fact that commercially available krill oil products are extremely low in EPA and DHA, while still costing much more than fish oil products (containing much more EPA and DHA). In fact, in the only trial comparing equivalent doses, researchers needed to use 14 krill oil capsules to get the same amount of EPA and DHA as 4 capsules of fish oil.

    Read More @ Pointe Institute

    Special Podcast by Dr. Ronald Hoffman

    Everything you ever wanted to know about fish oil:

    1. How to choose a good product
    2. enteric-coated vs. soft gel;
    3. EPA vs. DHA
    4. krill vs. fish body-derived;
    5. natural vs. prescription;
    6. ethyl ester vs. triglyceride;
    7. discount vs. premium.
    8. Why do some “authorities” claim fish oil is harmful or worthless?
    9. Why you should know your Omega 3:6 Index.

    Listen to Podcast here

  2. URGENT – Naturopathic doctors in Hawaii need your help

    hawaiindNaturopathic doctors in Hawaii need your help! Hawaiian legislative bill SB257 has passed the senate. If approved, this bill would revoke prescription rights for Hawaiian NDs. There is a hearing about the bill scheduled Thursday and written testimony from NDs, patients and colleagues is urgently requested.

    This is a serious concern to NDs in Hawaii, one of the more liberal allied states toward naturopathic medicine, but it may become a precedent that could lead toward national requirements for supervisory prescriptive rights by medical doctors for all NDs in the U.S..

    We are asking you to help us by signing the attached template  for an opposed testimony or using it to create personal testimony. Testimony is due by 10:30 a.m. tomorrow, Wednesday, 2/19.

    Please help! Your naturopathic colleagues in Hawaii will be very grateful.

    Mahalo nui loa!!

  3. Green Tea May Have Brain Healing Properties

    Green Tea May Have Brain Healing PropertiesBy Sayer Ji
    GreenMedInfo

    An exciting new study published in the journal Biochemical and Biophysical Research Communications reveals that green tea may have powerful brain healing properties, especially when it comes to preventing and perhaps even treating so-called ‘incurable’ neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Huntington’s disease.

    Titled, “Green tea catechins potentiate the neuritogenic action of brain-derived neurotrophic factor: role of 67-kDa laminin receptor and hydrogen peroxide,” the paper set out to explore green tea’s potential for increasing the activity of a nerve growth factor known as brain-derived neurotrophic factor (BDNF), essential for the growth, maintenance and survival of neurons:

         “Delivery of optimal amounts of brain-derived neurotrophic factor (BDNF) to
    regions of the brain affected by neurodegenerative diseases is a daunting task.
    Using natural products with neuroprotective properties, such as green tea
    polyphenols, would be a highly useful complementary approach for inexpensive
    long-term treatment of these diseases.”

     

    The researchers pointed out that increasing the production of BDNF in the brain is one approach worth pursuing, but that another “complementary approach” is “to potentiate the action of limited amounts of BDNF present in affected regions of the brain,” and that green tea may offer just that enhancement tool.

    The main perceived barrier to using EGCG in neurological problems, however, is that only very low levels are believed capable of reaching the brain.  Due to this limiting factor, the study also set out to ascertain what concentration ranges might produce a physiologically relevant effect in the brain.

    Using a cell model, the researchers chose a type of neuron which expresses a high affinity receptor (TrkB) for BDNF known as PC12(TrkB) cells. These cells, “differentiate and induce neurite outgrowth in response to BDNF.”  A neurite is any projection from the cell body of a neuron, usually either an axon or a dendrite.

    Read More